Skip to main content
CODX
NASDAQ Life Sciences

Co-Diagnostics JV Ships Ebola Test Kits for Evaluation, Advances Blood-Borne PCR Assay

Tom Rudovsky · Reported by PR Newswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.06
Mkt Cap
$10.769M
52W Low
$1.26
52W High
$46.5
52W Position info
63% above low
Off High info
96% below high
Rel. Volume
Market data snapshot near publication time

CODX sits 63% above its 52-week low of $1.26.

Summary

Co-Diagnostics' Indian joint venture CoSara has shipped Bundibugyo Ebola test kits to a third-party lab for analytical studies, responding to a request from India's C-CAMP. Separately, the company completed a proof-of-concept study for the first blood-borne Ebola test on its Co-Dx PCR Pro point-of-care instrument, expanding the platform beyond swab-based tests. These milestones demonstrate progress in pandemic preparedness and menu expansion, though the PCR platform is not yet authorized for sale. The news follows a series of dilutive financing moves and a going concern warning, but this product development update is a concrete step toward future revenue. No specific regulatory timeline was provided.

At the time of this announcement, CODX was trading at $2.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.8M. The 52-week trading range was $1.26 to $46.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CODX - Latest Insights

CODX
Nov 13, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2585
Real-time Price: $0.1884 info
Change: -$0.0701 (-27%) info
Market Cap: $2.078M info
CODX
Nov 10, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.2856
Real-time Price: $0.1884 info
Change: -$0.0972 (-34%) info
Market Cap: $2.078M info
CODX
Nov 10, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.3652
Real-time Price: $0.1884 info
Change: -$0.1768 (-48%) info
Market Cap: $2.078M info
CODX
Nov 04, 2026, 4:45 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.3615
Real-time Price: $0.1884 info
Change: -$0.1731 (-48%) info
Market Cap: $2.078M info
CODX
Oct 26, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.5459
Real-time Price: $0.1884 info
Change: -$0.3575 (-65%) info
Market Cap: $2.078M info